A model for type Ii diabetes in an HIV-infected patient under highly active antiretroviral therapy

2022 ◽  
Vol 155 ◽  
pp. 111716
Author(s):  
Joseph Páez Chávez ◽  
Karunia Putra Wijaya ◽  
Carla M.A. Pinto ◽  
Clara Burgos-Simón
Keyword(s):  
Antiretroviral Therapy ◽  
Highly Active Antiretroviral Therapy ◽  
Type Ii Diabetes ◽  
Infected Patient ◽  
Type Ii ◽  
Highly Active

Primary Isolate Neutralization by HIV Type 1-Infected Patient Sera in the Era of Highly Active Antiretroviral Therapy

1999 ◽  
Vol 15 (17) ◽  
pp. 1563-1571 ◽  
Author(s):  
Kimberly Dreyer ◽  
Esper G. Kallas ◽  
Vicente Planelles ◽  
David Montefiori ◽  
Michael P. McDermott ◽  
...  
Keyword(s):  
Antiretroviral Therapy ◽  
Highly Active Antiretroviral Therapy ◽  
Infected Patient ◽  
Primary Isolate ◽  
Highly Active ◽  
Hiv Type 1

Response to highly active antiretroviral therapy as the only therapy in an HIV-infected patient with interfollicular Hodgkin's lymphoma

2007 ◽  
Vol 48 (10) ◽  
pp. 2058-2059 ◽  
Author(s):  
Blanca Xicoy ◽  
Josep-María Ribera ◽  
Joan Romeu ◽  
José-Luís Mate ◽  
Fuensanta Millà ◽  
...  
Keyword(s):  
Antiretroviral Therapy ◽  
Highly Active Antiretroviral Therapy ◽  
Infected Patient ◽  
Hodgkin’S Lymphoma ◽  
Hodgkin's Lymphoma ◽  
Highly Active

Subcutaneous granulomatous lesions related to ritonavir therapy in a HIV infected patient

2002 ◽  
Vol 13 (4) ◽  
pp. 273-274 ◽  
Author(s):  
M Kawsar ◽  
S El-Gadi
Keyword(s):  
Antiretroviral Therapy ◽  
Side Effects ◽  
Highly Active Antiretroviral Therapy ◽  
Infected Patient ◽  
Close Monitoring ◽  
Highly Active ◽  
Granulomatous Lesions ◽  
Hiv Seropositive

We report a case of subcutaneous granulomatous lesions developed in a HIV seropositive man, related to ritonavir therapy. The importance of close monitoring and investigations of patients developing unusual side effects during highly active antiretroviral therapy (HAART) is demonstrated.

Sign in / Sign up

Export Citation Format

Share Document